Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search

Print

2020 Press Releases

-Archives-

Inside the new mRNA vaccines for COVID-19

Inside the new mRNA vaccines for COVID-19

The new vaccines by Pfizer/BioNTech and Moderna use messenger RNA to stimulate the immune system to protect against COVID-19. These vaccines are the first of their kind and researchers at UMass Medical School are among the leading RNA biologists in the world.

UMass Memorial providers receive first COVID shots at UMMS

UMass Memorial providers receive first COVID shots at UMMS

The word on everyone’s lips was “excited” as the first UMass Memorial Medical Center University Campus health care providers rolled up their sleeves Dec. 17 to receive their inoculation with the Pfizer/BioNTech COVID-19 vaccine.

COVID vaccines arrive in Worcester; health care providers, staff first to be inoculated

COVID vaccines arrive in Worcester; health care providers, staff first to be inoculated

Frontline health care workers employed by UMass Memorial Health Care are among those expected to receive vaccinations against the SARS-CoV-2 virus that causes COVID-19 beginning this week.

UMMS study shows how novel mechanism in P. aeruginosa bacteria disables ribosome

UMMS study shows how novel mechanism in P. aeruginosa bacteria disables ribosome

A new study by Alejandro Vasquez-Rifo, PhD, and Victor Ambros, PhD, shows that certain strains of Pseudomonas aeruginosa, a rod-shaped bacterial pathogen that causes disease in plants and animals, including humans, have a unique mechanism for disabling and degrading the ribosome in its host cells.

Parth Chakrabarti named executive vice chancellor for innovation and business development

Parth Chakrabarti named executive vice chancellor for innovation and business development

Parth Chakrabarti, MPH, MBA, an experienced strategic leader in the pharmaceutical and biotech industry, will serve as UMass Medical School’s new executive vice chancellor for innovation and business development.

UMass Medical School joins Autism Learning Health Network

UMass Medical School joins Autism Learning Health Network

The Eunice Kennedy Shriver Center’s Center for Autism and Neurodevelopmental Disorders clinic, in partnership with the Division of Developmental Behavioral Pediatrics, has joined the Autism Learning Health Network of Autism Speaks to improve care for affected children and families.

Robert Finberg details next steps for COVID vaccine

Robert Finberg details next steps for COVID vaccine

Robert W. Finberg, MD, a member of Gov. Charlie Baker’s COVID-19 Vaccine Advisory Group, explains the process of getting the population vaccinated that will play out in phases over the coming year.

Protein commonly screened for in pregnancy is linked to gestational diabetes

Protein commonly screened for in pregnancy is linked to gestational diabetes

New research by Silvia Corvera, MD, and Tiffany Moore Simas, MD, MPH, MEd, show that low levels of a protein commonly seen in screening tests for chromosomal disorders is associated with adipose tissue remodeling, glucose resistance and gestational diabetes mellitus in pregnant women.

NIH research funding surges at UMass Medical School

NIH research funding surges at UMass Medical School

National Institutes of Health research funding to UMass Medical School grew by 78 percent for the first quarter of fiscal 2021, which began July 1. Grants and contracts from all funding sources increased by nearly 50 percent.

New study co-authored by MD/PhD student Benjamin Helfand shows frequent delirium in older COVID patients

New study co-authored by MD/PhD student Benjamin Helfand shows frequent delirium in older COVID patients

MD/PhD student Benjamin Helfand is co-first author on a study published in the Journal of American Medical Association Network Open that examines the frequency of COVID-19 positive older adults presenting to the emergency department with delirium.